FAMI
EXAS

Fideuram Asset Management (Ireland)’s Exact Sciences EXAS Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54
Closed -$3.1K – 548
2025
Q4 		$3.1K Buy
+54
New +$4.34K ﹤0.01% 616

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s EXAS Position: Q1 2026 in Review

Fideuram Asset Management (Ireland) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 54 shares — an estimated $3.1K sold.

Fideuram Asset Management (Ireland) first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $3.1K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fideuram Asset Management (Ireland) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fideuram Asset Management (Ireland) sold 54 Exact Sciences shares in Q1 2026, an estimated $3.1K.
  • Fideuram Asset Management (Ireland) first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Fideuram Asset Management (Ireland)'s Exact Sciences position peaked at $3.1K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q1 2026, filed 11 May 2026.